Author:
Paschke R.,Schwedes U.,Kühnle H.,Peter J.,Schmeidl R.,Usadel K. H.
Publisher
Springer Science and Business Media LLC
Subject
General Medicine,Genetics(clinical),Drug Discovery,Molecular Medicine
Reference20 articles.
1. Adnitt PI (1968) Hypoglycemic Action of Monoamineoxidase Inhibitors. Diabetes 17:628–633
2. Deaciuc IV, Kühnle HF, Strauss KM, Schmidt FH (1983) Studies on the mechanism of action of the hypoglycemic agent, 2-(3-Methylcinnamylhydrazono)-propionate (BM 42.304). J Pharmacol 32:3405–3412
3. Dimitriadis G, Raptis S, Hatziagelaki E, Mitrakou A, Halvatsiotis P, Ladas S, Hillebrand I (1986) Effects of two new a-glycosidase inhibitors on glycemic control in patients with insulin-dependent diabetes mellitus. Klin Wochenschr 64:405–410
4. Di Tullio NW, Berkhoff CE, Blank B, Kostos V, Stack EJ, Saunders HL (1974) 3-Mercaptopicolinic acid, an inhibitor of gluconeogenesis. Biochem J 138:387–394
5. Haeckel R, Oellerich M (1977) The influence of hydrazine, phenelzine and nialamide on gluconeogenesis and cell respiration in the perfused guinea-pig liver. Eur J Clin invest 7:393–400